Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending September 30, 2022 was $-3.09 Million (a -26.42% decrease compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense increased by 92.7%
- Annual Non-operating Income/Expense for 2021 was $-2.22 Million (a -73.63% decrease from previous year)
- Annual Non-operating Income/Expense for 2020 was $-8.42 Million (a 111.19% increase from previous year)
- Annual Non-operating Income/Expense for 2019 was $-3.99 Million (a -168.51% decrease from previous year)
- Twelve month Non-operating Income/Expense ending September 30, 2022 was $-10 Million (a 87.23% increase compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense increased by 351.33% year-over-year
Trailing Non-operating Income/Expense for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $-10 Million | $-5.35 Million | $-1.97 Million | $-2.22 Million |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Biodesix, Inc.
Most recent Non-operating Income/Expenseof BDSX including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Biodesix, Inc.
Biodesix, Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-3.09 | $-4.2 | $-1.13 | – |
| 2021 | $-1.6 | $1.58 | $-0.82 | $-1.38 | $-2.22 |
| 2020 | $-1.88 | $-2.61 | $-2.65 | $-1.28 | $-8.42 |
| 2019 | – | – | $3.76 | $-0.57 | $-3.99 |
| 2018 | – | – | – | – | $5.82 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research